These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19930099)

  • 1. Statins and amyotrophic lateral sclerosis--the level of evidence for an association.
    Sørensen HT; Lash TL
    J Intern Med; 2009 Dec; 266(6):520-6. PubMed ID: 19930099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and risk of amyotrophic lateral sclerosis and other motor neuron disorders.
    Sørensen HT; Riis AH; Lash TL; Pedersen L
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):413-7. PubMed ID: 20530788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.
    Golomb BA; Kwon EK; Koperski S; Evans MA
    Drug Saf; 2009; 32(8):649-61. PubMed ID: 19591530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis.
    Drory VE; Bronipolsky T; Artamonov I; Nefussy B
    J Neurol Sci; 2008 Oct; 273(1-2):81-3. PubMed ID: 18678378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins--the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database].
    Buajordet I; Madsen S; Olsen H
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3210-3. PubMed ID: 9411859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
    Kashani A; Sallam T; Bheemreddy S; Mann DL; Wang Y; Foody JM
    Am J Cardiol; 2008 Jun; 101(11):1606-13. PubMed ID: 18489938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety profile of statins].
    Prieto JC
    Rev Med Chil; 2001 Nov; 129(11):1237-40. PubMed ID: 11836874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential association between statin exposure and elevated levels of creatine kinase.
    Chan J; Hui RL; Levin E
    Ann Pharmacother; 2005 Oct; 39(10):1611-6. PubMed ID: 16160000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Jamal SM; Eisenberg MJ; Christopoulos S
    Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis.
    Nefussy B; Hirsch J; Cudkowicz ME; Drory VE
    J Neurol Sci; 2011 Jan; 300(1-2):23-7. PubMed ID: 21056430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.
    Golomb BA; Verden A; Messner AK; Koslik HJ; Hoffman KB
    Drug Saf; 2018 Apr; 41(4):403-413. PubMed ID: 29427042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis associated with statins. A disproportionality analysis of the WHO Program for International Drug Monitoring database (VigiBase).
    Macías Saint-Gerons D; Castro JL
    Eur J Clin Pharmacol; 2019 Apr; 75(4):587-589. PubMed ID: 30470902
    [No Abstract]   [Full Text] [Related]  

  • 18. Are statin medications safe in patients with ALS?
    Zinman L; Sadeghi R; Gawel M; Patton D; Kiss A
    Amyotroph Lateral Scler; 2008 Aug; 9(4):223-8. PubMed ID: 18608105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins for stroke prevention: disappointment and hope.
    Amarenco P; Tonkin AM
    Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins, low-density lipoprotein cholesterol, and risk of cancer.
    Alsheikh-Ali AA; Trikalinos TA; Kent DM; Karas RH
    J Am Coll Cardiol; 2008 Sep; 52(14):1141-7. PubMed ID: 18804740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.